Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001161697-21-000011
Filing Date
2021-01-04
Accepted
2021-01-04 16:34:03
Documents
1
Period of Report
2020-12-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 FOR 12-30-2020 form4.html 4  
1 FORM 4 FOR 12-30-2020 form4.xml 4 3902
  Complete submission text file 0001161697-21-000011.txt   5532
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1500 CORAL GABLES FL 33134
Business Address
DENKHAUS DONALD A (Reporting) CIK: 0001278439 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33057 | Film No.: 21502195

Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Issuer) CIK: 0001369568 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations